- Alcon and J&J Surgical Vision exchanged cross-licenses of certain intellectual property
- Alcon will make a one-time payment of $199m to J&J Surgical Vision
- NOTE: In 2020,
J&J Sues Alcon Over Patents for Laser Eye Surgery
NOTE
- Novartis AG fell 0.4% to CHF79.77 as of last close
- The average 12-month price target of CHF89.41 is 12.1% above the current price
- 14 buys, 12 holds, 4 sells
- Alcon Inc. fell 1.6% to ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.